• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

DDI Webinar - Introduction to Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER - February 11, 2014

The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) is again delighted to present a series of educational webinars targeting the needs of all Healthcare Professionals, Pharmacy students, Nurse Practitioner students, Physician Assistant and Medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation.

 
These focused webinars support FDA's mission of promoting and protecting public health, through interaction and education to strengthen relationships with future clinicians, researchers, nurses, and pharmacists. Fostering this connection will provide a better understanding of FDA's role in public health as a regulatory agency.
 
On February 11, 2014, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: "Introduction to Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER," the featured speaker, CDR Selena Ready, Pharm.D., CGP, gave an overview of pharmacovigilance: the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or other drug-related problems.
 

If you've never used Connect Pro, get a quick overview:
http://www.adobe.com/go/connectpro_overview 

Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.